Immune Thrombocytopenia following COVID-19 Vaccine

Several vaccines have been developed and are being administered against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Common side effects include fever, chills, headache, myalgia, and soreness at the injection site. However, some rare adverse effects have also been reported. We prese...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasad, Sonal, Jariwal, Roopam, Adebayo, Moujidin, Jaka, Sara, Petersen, Greti, Cobos, Everardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252767/
https://www.ncbi.nlm.nih.gov/pubmed/35795543
http://dx.doi.org/10.1155/2022/6013321
Descripción
Sumario:Several vaccines have been developed and are being administered against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Common side effects include fever, chills, headache, myalgia, and soreness at the injection site. However, some rare adverse effects have also been reported. We present a case of induced thrombocytopenia presenting with petechiae and mucosal bleeding which developed as an adverse response after first-dose administration of the Moderna COVID-19 vaccine.

Ejemplares similares